FDA: Pharmakon Pharmaceuticals recalls all sterile compounded products

Editor's Note

The Food and Drug Administration (FDA) on April 20 announced that Pharmakon Pharmaceuticals (Noblesville, Indiana) issued a nationwide recall of all sterile compounded products because of a lack of sterility assurance and other quality issues.

The sterile products were distributed between March 4 and April 15, 2016.

UPDATED 04/20/2016. Pharmakon issues nationwide issued a voluntary nationwide recall of all sterile compounded products. All recalled products have a label that includes the Pharmakon Pharmaceuticals name, address and expiration date. The sterile products were distributed nationwide to hospitals between March 4, 2016 and April 15, 2016.